Nicole Anders

Research Associate

20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicole Anders is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Characterization of an Adapted Murine Model of Intrauterine Inflammation–Induced Preterm Birth

Zierden, H. C., Ortiz Ortiz, J. I., Dimitrion, P., Laney, V., Bensouda, S., Anders, N. M., Scardina, M., Hoang, T., Ronnett, B. M., Hanes, J., Burd, I., Mahendroo, M. & Ensign, L. M., Feb 2020, In : American Journal of Pathology. 190, 2, p. 295-305 11 p.

Research output: Contribution to journalArticle

  • Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids

    Hernandez, D., Palau, L., Norsworthy, K., Anders, N. M., Alonso, S., Su, M., Petkovich, M., Chandraratna, R., Rudek, M. A., Smith, B. D., Jones, R. J. & Ghiaur, G., Jan 1 2020, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalLetter

    Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization

    Hackett, S. F., Fu, J., Kim, Y. C., Tsujinaka, H., Shen, J., Lima e Silva, R., Khan, M., Hafiz, Z., Wang, T., Shin, M., Anders, N. M., He, P., Ensign, L. M., Hanes, J. & Campochiaro, P. A., Jun 2020, In : Biomaterials. 243, 119935.

    Research output: Contribution to journalArticle

  • A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors

    Gaillard, S. L., Zahurak, M., Sharma, A., Durham, J. N., Reiss, K. A., Sartorius-Mergenthaler, S., Downs, M., Anders, N. M., Ahuja, N., Rudek, M. A. & Azad, N., Aug 15 2019, In : Cancer. 125, 16, p. 2837-2845 9 p.

    Research output: Contribution to journalArticle

  • Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth

    Hoang, T., Zierden, H., Date, A., Ortiz, J., Gumber, S., Anders, N., He, P., Segars, J., Hanes, J., Mahendroo, M. & Ensign, L. M., Feb 10 2019, In : Journal of Controlled Release. 295, p. 74-86 13 p.

    Research output: Contribution to journalArticle